Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

ClinicalTrials.gov ID: NCT02495415

Public ClinicalTrials.gov record NCT02495415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Intravenous Fenretinide (N-(4-hydroxyphenyl) Retinamide, 4-HPR) Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas (PTCL)

Study identification

NCT ID: NCT02495415
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: CerRx, Inc.; Industry
Enrollment: 140 participants

Conditions and interventions

Conditions

Peripheral T-cell Lymphoma

Interventions

Fenretinide Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2016
Primary completion: Jun 30, 2021
Completion: Nov 30, 2021
Last update posted: Jul 22, 2019

2016 – 2021

United States locations

U.S. sites: 11
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
Banner MD Anderson Cancer Center	Gilbert	Arizona	85234	Recruiting
USC Norris Comprehensive Cancer Center	Los Angeles	California	90033	Recruiting
University of California, Los Angeles	Los Angeles	California	90095	Recruiting
Emory University	Atlanta	Georgia	30322	Recruiting
University of Kansas Cancer Center	Westwood	Kansas	66205	Recruiting
Norton Healthcare	Louisville	Kentucky	40202	Recruiting
University of Louisville	Louisville	Kentucky	40202	Recruiting
Hackensack University Medical Center	Hackensack	New Jersey	07601	Recruiting
Bon Secours Saint Francis Cancer Center	Greenville	South Carolina	29607	Recruiting
Baylor University Medical Center	Dallas	Texas	75246	Recruiting
University of Texas, Southwestern	Dallas	Texas	75390	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02495415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 22, 2019 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02495415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →